Pearl Therapeutics Overview
- Year Founded
-
2006
- Status
-
Acquired/Merged
- Employees
-
134
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$1.16B
- Investors
-
1
Pearl Therapeutics General Information
Description
Developer of therapies for the treatment of prevalent respiratory diseases. The company offers innovative solutions and products designed to address conditions such as chronic obstructive pulmonary disease, rhinosinusitis, and asthma, enabling healthcare professionals to improve patient outcomes, improve quality of life, and advance respiratory health care.
Contact Information
Website
www.pearltherapeutics.com(Operating Subsidiary)
Corporate Office
- 200 Saginaw Drive
- Redwood City, CA 94063
- United States
Corporate Office
- 200 Saginaw Drive
- Redwood City, CA 94063
- United States
Pearl Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Merger/Acquisition | 27-Jun-2013 | $1.16B | Completed | Clinical Trials - General | ||
| 4. Later Stage VC (Series D) | 11-Feb-2013 | Completed | Clinical Trials - General | |||
| 3. Later Stage VC (Series C) | 19-Oct-2010 | Completed | Startup | |||
| 2. Debt - General | 24-Feb-2009 | $8M | $41.5M | Completed | Startup | |
| 1. Early Stage VC (Series B) | 01-Jul-2008 | $33.5M | $33.5M | Completed | Startup |
Pearl Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series D | ||||||||
| Series C | ||||||||
| Series B | 34,000,000 | $0.001000 | 8% | $1 | $0.51 | 0x | $0.51 | 18.47% |
| Series A | 4,770,037 | $0.001000 | 8% | $1.05 | $1.05 | 1x | $1.05 | 1.32% |
Pearl Therapeutics Comparisons
Industry
Financing
Details
Pearl Therapeutics Competitors (44)
One of Pearl Therapeutics’s 44 competitors is Enterprise Therapeutics, a Venture Capital-Backed company based in Brighton, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Enterprise Therapeutics | Venture Capital-Backed | Brighton, United Kingdom | ||||
| Cerecin | Venture Capital-Backed | Broomfield, CO | ||||
| Baliopharm | Venture Capital-Backed | Basel, Switzerland | ||||
| Verve Therapeutics | Formerly VC-backed | Boston, MA | ||||
| Verona Pharma | Corporate Backed or Acquired | London, United Kingdom |
Pearl Therapeutics Patents
Pearl Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2021260591-A1 | Methods of reducing mortality in patients suffering from copd | Inactive | 24-Jun-2020 | ||
| EP-4091652-B1 | Aerosol delivery unit | Active | 09-Oct-2017 | ||
| ES-2970740-T3 | Aerosol delivery unit | Active | 09-Oct-2017 | ||
| JP-2022122887-A | Drug delivery system and related methods | Active | 09-Oct-2017 | ||
| EP-3694590-B1 | Drug delivery systems | Active | 09-Oct-2017 | A61M15/0025 |
Pearl Therapeutics Signals
Pearl Therapeutics Former Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| 5AM Ventures | Venture Capital | Minority | ||
| Nektar Therapeutics | Corporation | Minority | ||
| New Leaf Venture | Venture Capital | Minority | ||
| Vatera Healthcare Partners | Venture Capital | Minority |
Pearl Therapeutics FAQs
-
When was Pearl Therapeutics founded?
Pearl Therapeutics was founded in 2006.
-
Where is Pearl Therapeutics headquartered?
Pearl Therapeutics is headquartered in Redwood City, CA.
-
What is the size of Pearl Therapeutics?
Pearl Therapeutics has 134 total employees.
-
What industry is Pearl Therapeutics in?
Pearl Therapeutics’s primary industry is Drug Discovery.
-
Is Pearl Therapeutics a private or public company?
Pearl Therapeutics is a Private company.
-
What is the current valuation of Pearl Therapeutics?
The current valuation of Pearl Therapeutics is .
-
What is Pearl Therapeutics’s current revenue?
The current revenue for Pearl Therapeutics is .
-
How much funding has Pearl Therapeutics raised over time?
Pearl Therapeutics has raised $175M.
-
Who are Pearl Therapeutics’s investors?
5AM Ventures, Nektar Therapeutics, New Leaf Venture, and Vatera Healthcare Partners have invested in Pearl Therapeutics.
-
Who are Pearl Therapeutics’s competitors?
Enterprise Therapeutics, Cerecin, Baliopharm, Verve Therapeutics, and Verona Pharma are some of the 44 competitors of Pearl Therapeutics.
-
When was Pearl Therapeutics acquired?
Pearl Therapeutics was acquired on 27-Jun-2013.
-
Who acquired Pearl Therapeutics?
Pearl Therapeutics was acquired by AstraZeneca.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process